EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-guided design of Anaplasma P44 protein-based chimeric antigens for serodiagnosis of anaplasmosis in dogs

Nicholas A Cramer iD, Kalvis Brangulis, Shane N Mann iD, Fabio M Herrera, Edward B Breitschwerdt iD, Jason A Carlyon iD, Richard T Marconi iD

Infection and Immunity · 2026

DOI: 10.1128/iai.00167-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, 2026. Verfasst von Nicholas A Cramer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Anaplasmosis, Dog Diseases, Anaplasma, Serologic Tests. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Diamond Light Source, Virginia Commonwealth University Commercialization Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canine and human anaplasmosis are tick-borne diseases caused by the obligate intracellular bacteria, Anaplasma phagocytophilum and Anaplasma platys , respectively. In veterinary medicine, peptides derived from the immunodominant P44 protein are used to detect antibodies in serological point-of-care tests for anaplasmosis. To inform efforts to develop improved chimeric diagnostic proteins for anaplasmosis, the structure of the predicted surface-exposed domain (residues 151–308) of P44 was determined at a resolution of 1.65 Å. This domain comprises six α-helices and six short β-strands connected by loop regions. A structural similarity search of the P44 151–308 domain using the Distance Matrix Alignment server against the AlphaFold Database revealed that the domain represents a previously uncharacterized protein fold. The determined structure is consistent with AlphaFold v2 predictions, which further predict the core of P44 to be an eight-stranded β-barrel. Using P44 fragments, immunodominant epitopes were mapped within residues 151–308. Four chimeric genes (ADC1, ADC2, ADC3, and ADC4) were designed that incorporate the analogous immunodominant P44 domains from A. phagocytophilum and A. platys . The recombinant ADC chimerics were assessed for sensitivity and specificity by screening with serum from dogs diagnosed with anaplasmosis, Lyme disease, or ehrlichiosis, with sera from specific pathogen-free dogs serving as negative controls. Accuracy was further demonstrated by screening characterized serum samples from coyotes ( Canis latrans ; wild canids). The ADC1 chimeric provided 100% sensitivity and 98.04% specificity. The sensitivity and specificity of ADC1 support its potential use as a diagnostic Ag for anaplasmosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaplasmosisDog DiseasesAnaplasmaSerologic TestsAntigens, BacterialBacterial ProteinsAnimalsDogsAntibodies, BacterialRecombinant Fusion ProteinsModels, MolecularAmino Acid SequenceBacterial Outer Membrane Proteins

Stichwörter der Autor:innen

P44anaplasmosiscanineschimericschimeritopesdiagnostics

Substanzen

Antigens, BacterialAntibodies, Bacterialp44 protein, Anaplasma phagocytophilaBacterial ProteinsRecombinant Fusion ProteinsBacterial Outer Membrane Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
  • National Institute of Research and Innovation, Riga, Latvia.
  • Intracellular Pathogens Research Laboratory, Comparative Medicine Institute, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Nicholas A Cramer, Shane N Mann, Edward B Breitschwerdt, Jason A Carlyon, Richard T Marconi

Förderung

  • NIH HHS
  • Diamond Light Source
  • Virginia Commonwealth University Commercialization Fund
  • National Institutes of Health

Zitieren

APA

Cramer, N. A., Brangulis, K., Mann, S. N., Herrera, F. M., Breitschwerdt, E. B., Carlyon, J. A., & Marconi, R. T. (2026). Structure-guided design of Anaplasma P44 protein-based chimeric antigens for serodiagnosis of anaplasmosis in dogs. Infection and Immunity. https://doi.org/10.1128/iai.00167-26

Vancouver

Cramer NA, Brangulis K, Mann SN, Herrera FM, Breitschwerdt EB, Carlyon JA, et al. Structure-guided design of Anaplasma P44 protein-based chimeric antigens for serodiagnosis of anaplasmosis in dogs. Infection and Immunity. 2026. doi:10.1128/iai.00167-26

BibTeX
@article{Cramer2026,
  author = {Cramer, Nicholas A and Brangulis, Kalvis and Mann, Shane N and Herrera, Fabio M and Breitschwerdt, Edward B and Carlyon, Jason A and Marconi, Richard T},
  title = {Structure-guided design of Anaplasma P44 protein-based chimeric antigens for serodiagnosis of anaplasmosis in dogs},
  journal = {Infection and Immunity},
  year = {2026},
  doi = {10.1128/iai.00167-26}
}
Kostenlos starten →